bortezomib
Ligand Summary
A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
UNII: 69G8BD63PP
PubChem: 387447
Guide to Pharmacology: 6391
ChEMBL: CHEMBL325041
DrugCentral: 391
LyCHI: HBWAWX2HPNMG
Target Activities
71 Activities
Items per page:
10
1 – 10 of 71
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||